Treatment For Kidney Cancer

EDM number 491 in 2010-12, proposed by Sharon Hodgson on 13/07/2010.
Categorised under the topics of Diseases and Health services.

That this House observes that between 7,000 and 8,000 people are diagnosed with kidney cancer in the UK each year, and that around 40 per cent. of patients have advanced cancer at the time of diagnosis; notes that everolimus is the only licensed treatment for patients with advanced and/or metastatic renal cell carcinoma who have failed on first-line treatment; notes with concern that the National Institute for Health and Clinical Excellence (NICE) has not recommended funding for everolimus; is concerned by the number of clinically effective cancer drugs which are turned down by NICE despite additional guidance on end-of-life medicines issued by NICE to the appraisal committees; and calls on NICE to reconsider its recommendations so that patients may be able to access this drug on the NHS.

This motion has been signed by a total of 44 MPs, 1 of these signatures have been withdrawn.